Study of the Stability of Zeolites in Model Biological Environments

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The stability of synthetic and natural zeolites in model biological media simulating the environment of the stomach (pH 1.8), blood plasma (pH 6.9), and intestines (pH 8) is studied. The effect of long-term exposure (up to 7 days) to biological media on the crystal structure of Beta, Rho, Y, and clinoptilolite zeolites is studied. The degree of degradation of the crystal structure of zeolites is controlled by X-ray phase analysis. Based on the results obtained, conclusions are drawn on the prospects for the use of synthetic and natural zeolites as drug carriers.

Авторлар туралы

N. Ul’yanova

Grebenshchikov Institute of Silicate Chemistry, Russian Academy of Sciences, 199034, St. Petersburg, Russia

Email: ternovayanatali@gmail.com
Россия, 199034, Санкт-Петербург, наб. Макарова, 2

E. Brazovskaya

Grebenshchikov Institute of Silicate Chemistry, Russian Academy of Sciences, 199034, St. Petersburg, Russia

Email: ternovayanatali@gmail.com
Россия, 199034, Санкт-Петербург, наб. Макарова, 2

O. Golubeva

Grebenshchikov Institute of Silicate Chemistry, Russian Academy of Sciences, 199034, St. Petersburg, Russia

Хат алмасуға жауапты Автор.
Email: ternovayanatali@gmail.com
Россия, 199034, Санкт-Петербург, наб. Макарова, 2

Әдебиет тізімі

  1. Bacakova L., Vandrovcova M., Kopova I., Jirka I. Applications of zeolites in biotechnology and medicine – a review // Biomater. Sci. 2018. V. 6 № 5. P. 974–989.
  2. Vallet-Regı´ M., Colilla M., Izquierdo-Barba I., Manzano M. Mesoporous silica nanoparticles for drug delivery: current insights // Molecules. 2018. V. 23. № 1. P. 47.
  3. Trewyn B.G., Giri S., Slowing I.I., Lin V.S.Y. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems // Chem. Commun. 2000. V. 31. P. 3236–3245.
  4. Rimoli M.G., Rabaioli M.R., Melisi D., Curcio A., Mondello S., Mirabelli R. Synthetic zeolites as a new tool for drug delivery // J. Biomed Mater. Res. A. 2008. V. 87. P. 156–164.
  5. Kontogiannidou E. In vitro and ex vivo assessment of microporous Faujasite zeolite (NaX-FAU) as a carrier for the oral delivery of danazol // J. Drug Delivery Sci. Technol. 2019. V. 51. P. 177–184.
  6. Golubeva O.Yu., Brazovskaya E.Y., Alikina Y.A., D’yachenko S., Zhernovoi A. Synthesis and study of nanocomposites based on beta zeolite and magnetite for targeted drug delivery // Glass Physics and Chemistry. 2019. V. 45 № 1. P. 66–73.
  7. Koubaissy B., Toufaily J., Yaseen Z., Daou T.J., Jradi S., Hamieh T. Adsorption of uremic toxins over dealuminated zeolites // Adsorpt. Sci. Technol. 2017. V. 35. № 1. P. 3–19.
  8. Cheah W.K., Ishikawa K., Othman R., Yeoh F.Y. Nanoporous biomaterials for uremic toxin adsorption in artificial kidney systems: a review // J. Biomed. Mater. Res. Part B: Appl. Biomater. 2017. V. 105. № 5. P. 1232–124.
  9. Ульянова Н.Ю., Куриленко Л.Н., Шамова О.В., Орлов Д.С., Голубева О.Ю. Гемолитическая активность и сорбционная способность наночастиц цеолита BETA // Физика и химия стекла. 2020. Т. 46. № 2. С. 174–183.
  10. Souza I.M.S., García-Villén F., Viseras C., Perger S.B.C. Zeolites as Ingredients of Medicinal Products // Pharmaceutics. 2023. V. 15. № 5. P. 1352.
  11. Widder K.J., Senyei A.E., Scarpelli D.G. Magnetic microspheres: a model system for site specific drug delivery in vivo // Experimental Biology and Medicine. 1978. V. 158. № 2. P. 141–146.
  12. Shreya A.B., Raut S.Y., Managuli R.S., Udupa N., Mutalik S. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances // AAPS PharmSciTech. 2018. V. 20. № 1. 15.
  13. Homayun B., Lin X., Choi H.J. Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals // Pharmaceutics. 2019. V. 11. № 3. P. 129.
  14. Rouge N., Buri P., Doelker E., Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery // Int. J. Pharmaceut. 1996. V. 136. P. 117–139.
  15. Thakral S., Thakral N.K., Majumdar D.K. Eudragit: a technology evaluation // Expert Opin. Drug Deliv. 2013. V. 10. № 1. P. 131–149.
  16. Liu L., Yao W., Rao Y., Lu X., Gao J. PH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms // Drug Delivery. 2017. V. 24 № 1. P. 569–581.
  17. Tas A.C., A Cuneyt Tas. Synthesis of biomimetic Ca-hydroxyapatite powders at 37°C in synthetic body fluids // Biomaterials. 2000. V. 21. № 14. P. 1429–1438.
  18. Tang T., Zhang L., Dong H., Fang Z., Yu Q., Tang T. The Royal Society of Chemistry 2017 // RSC Adv. 2017. V. 7. P. 7711–7717.
  19. Robson H. Verified synthesis of zeolitic materials. Amsterdam: Elsevier, 2016.
  20. Golubeva O.Yu., Ul’yanova N.Yu., Stabilization of silver nanoparticles and clusters in porous zeolite matrices with Rho, Beta, and Paulingite structures // Glass Physics and Chemistry. 2015. V. 41. № 5. P. 537–544.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу
2.

Жүктеу (453KB)
Метадеректер

© Н.Ю. Ульянова, Е.Ю. Бразовская, О.Ю. Голубева, 2023